$INKS Artemis Therapeutics, Inc. Insider Trading
Get free email notifications about insider trading in Artemis Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Artemis Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Artemis Therapeutics, Inc. for free.
CIK Number: 0001062128
IRS Number: 841417774
Industry: MISCELLANEOUS CHEMICAL PRODUCTS [2890]
Trading Symbol: INKS
Company Address: 18 EAST 16TH STREET NEW YORK 10003
Phone number: 646-233-1454
Former name: INKSURE TECHNOLOGIES INC, date of change: 1998-05-19
Former name: NEW YORK GLOBAL INNOVATIONS INC., date of change: 2014-03-05
Prev close: $0.02
Average Daily Volume: 36,562
Days Low: $0.00
Year Low: $0.01
Year High: $0.04
Artemis Therapeutics, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 19 2018 | INKS | Artemis Therapeuti ... | Peleg Gadi | Director | Sell | S | 0.26 | 182 | 47 | 5,374 | 5.6 K to 5.4 K (-3.28 %) |
Mar 19 2018 | INKS | Artemis Therapeuti ... | Culley Brian M | Chief Executive Off ... | Option Exercise | A | 1.30 | 48,528 | 63,086 | 48,528 | |
Mar 19 2018 | INKS | Artemis Therapeuti ... | Morris Chanan | Chief Financial Off ... | Option Exercise | A | 1.30 | 50,000 | 65,000 | 50,000 | |
Oct 25 2017 | INKS | Artemis Therapeuti ... | Culley Brian M | Chief Executive Off ... | Option Exercise | P | 2.00 | 12,500 | 25,000 | 12,500 | |
Oct 25 2017 | INKS | Artemis Therapeuti ... | Culley Brian M | Chief Executive Off ... | Buy | P | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
Sep 05 2017 | INKS | Artemis Therapeuti ... | Culley Brian M | Chief Executive Off ... | Option Exercise | A | 1.30 | 242,640 | 315,432 | 242,640 | |
Jun 28 2017 | INKS | Artemis Therapeuti ... | Wolf Dana | Chief Scientific Of ... | Option Exercise | M | 0.01 | 35,202 | 352 | 70,406 | |
Jun 28 2017 | INKS | Artemis Therapeuti ... | Wolf Dana | Chief Scientific Of ... | Buy | M | 0.01 | 35,202 | 352 | 35,202 | 0 to 35.2 K |
Jul 17 2012 | INKS | NEW YORK GLOBAL IN ... | Goldovsky Viktor | VP Sales and Buisne ... | Option Exercise | A | 0.13 | 400,000 | 50,000 | 400,000 | |
Feb 16 2012 | INKS | NEW YORK GLOBAL IN ... | Gilat Tal | President and CEO | Grant | A | 0.00 | 2,055,604 | 0 | 2,055,604 | 0 to 2.1 M |
Mar 08 2011 | INKS | NEW YORK GLOBAL IN ... | Schoenheimer Pierre Lucien | Director | Sell | S | 0.18 | 10,000 | 1,800 | 2,361,000 | 2.4 M to 2.4 M (-0.42 %) |
Mar 07 2011 | INKS | NEW YORK GLOBAL IN ... | Peleg Gadi | Chairman of the Boa ... | Grant | A | 0.18 | 277,778 | 50,000 | 4,227,778 | 4 M to 4.2 M (+7.03 %) |
Mar 07 2011 | INKS | NEW YORK GLOBAL IN ... | Raich Alon | Director | Grant | A | 0.18 | 62,500 | 11,250 | 332,500 | 270 K to 332.5 K (+23.15 %) |
Mar 07 2011 | INKS | NEW YORK GLOBAL IN ... | Bettsak Jonathan | Director | Grant | A | 0.18 | 48,611 | 8,750 | 3,248,611 | 3.2 M to 3.2 M (+1.52 %) |
Mar 07 2011 | INKS | NEW YORK GLOBAL IN ... | Schoenheimer Pierre Lucien | Director | Grant | A | 0.18 | 62,500 | 11,250 | 2,371,000 | 2.3 M to 2.4 M (+2.71 %) |